CAS: 376-68-1; Hexafluoroglutaric Anhydride

该化合物是氟化有机化合物,其独特结构包括二氢环和多种氟化替代物,其特点是氟化度高,具有独特的化学特性,如稳定性和疏水性增强;二氯酮功能组的存在有助于其反应,使其得以参与各种化学反应,包括核生殖添加和凝聚反应;其氟化性质使其对材料科学和药物感兴趣,氟化化合物往往在其中表现出更强的生物活动和性能特征;此外,该化合物的物理特性,例如沸点和溶液,受到氟含量的影响,使其与非氟化模拟物相比,极值较低;总体而言,3,34,4,45,5,5-5-六氟二氢-2,6(3H)-二酮是氟化学品研究及其应用的一个重要化合物.

结构式图片

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号376-73-8 六氟戊二酸 | CAS号678-77-3 氯化六氟戊二酸

合成工艺路线路线简述

  • 合成目标产物 Hexafluoroglutaric Anhydride 主要起始原料 1,2-Dichlorohexafluorocyclopentene
  • (文献来源)合成步骤主要原料 1,2-Dichlorohexafluorocyclopentene
六氟戊二酰氯 反应生成 六氟戊二酸酐
参考文献:全氟戊二酸二钠和全氟戊二酸酐在氟化钾上的热解
标题:全氟戊二酸二钠和全氟戊二酸酐在氟化钾上的热解
摘要:全氟戊二酸二钠的热解得到包含顺式和反式全氟丁-2-烯酰氟和全氟丁-3-烯酰氟的复杂产物.在420-450 Perfluoroglutaric酐过氟化钾的通道°也产生这些链烯酰基氟化物,其可被转化成混合的钠perfluorobutenoates的是,热解时,产生的混合物,尤其是,全氟(甲基乙炔).
DOI:10.1039/j39690001331

海关参考信息

专利信息


专利号:US-2023357257-A1
优先权日:2020-12-28
标 题 :Novel process for the synthesis of noroxymorphone from morphine
发明人:GORBACHEV DMITRY; LAM HON WAI; SAXENA AAKARSH; SAXENA NAVIN SATYAPAL
权利人:NAVIN SAXENA RESEARCH & TECH PVT LTD
摘要:The present invention relates to a novel, efficient, pot- and atom-economical, and industrially applicable process for converting morphine to noroxymorphone using reagents and solvents of lesser toxicity and lower cost with respect to those used in the prior art.

专利号:US-8017776-B2
优先权日:2003-07-15
标题 :Methods for synthesis of acyloxyalkyl compounds
发明人:BHAT LAXMINARAYAN; GALLOP MARK A
权利人:XENOPORT INC
摘要:Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.

专利号:EP-2354120-A1
优先权日:2003-08-20
标题 :Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
发明人:GALLOP MARK A; YAO FENMEI; LUDWIKOW MARIA J; PHAN THU; PENG GE
权利人:XENOPORT INC
摘要:The present invention relates to acyloxyalkyl carbamate prodrugs of (±)-4-amino-3-(4-fluorophenyl)butanoic acid and analogs thereof, pharmaceutical compositions thereof, methods of making prodrugs of (±)-4-amino-3-(4-fluorophenyl)butanoic acid and analogs thereof, methods of using prodrugs of (±)-4-amino-3-(4-tluorophenyl)butanoic acid and analogs thereof, and pharmaceutical compositions thereof for treating or preventing common diseases and/or disorders such as spasticity and/or acid reflux disease. The present invention also relates to acyloxyalkyl carbamate prodrugs of (±)-4-amino-3-(4-fluorophenyl)butanoic acid and analogs thereof which are suitable for oral administration and to sustained release oral dosage forms thereof.

专利号:US-8138272-B2
优先权日:2006-05-22
标 题:Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds
发明人:KONRADI ANDREI W; SMITH JENIFER L
权利人:KONRADI ANDREI W; SMITH JENIFER L; ELAN PHARM INC
摘要:This invention provides an improved synthesis of polymer conjugates of formula (I), n nof agricultural, therapeutic, and food additive compounds. In particular, a process is described for the preparation of conjugates by treating primary or secondary alcohol substituents of active compounds with polymeric nucleophiles using “Mitsunobuâ€? or related reaction conditions.

专利号:US-8372881-B2
优先权日:2005-06-20
标题 :Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
发明人:ZERANGUE NOA; JANDELEIT BERND; LI YUNXIAO; GALLOP MARK A
权利人:XENOPORT INC; ZERANGUE NOA; JANDELEIT BERND; LI YUNXIAO; GALLOP MARK A
摘要:Acyloxyalkyl carbamate prodrugs of trans-4-(aminomethyl)-cyclohexanecarboxylic acid, pharmaceutical compositions thereof, methods of making prodrugs of trans-4-(aminomethyl)-cyclohexane-carboxylic acid, and methods of using prodrugs of trans-4-(aminomethyl)-cyclohexanecarboxylic acid and pharmaceutical compositions thereof to treat or prevent various diseases or disorders are disclosed. Acyloxyalkyl carbamate prodrugs of trans-4-(aminomethyl)-cyclohexanecarboxylic acid and pharmaceutical compositions thereof suitable for oral and topical administration and for administration using sustained release dosage forms are also disclosed.

专利号:CA-3200832-A1
优先权日:2020-12-28
标 题:Novel process for the synthesis of noroxymorphone from morphine
常州市力仁医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.lirenchem.com
企业联系电话:0519-85859058,13915836899👤
📞常州市力仁医药科技有限公司 ⚠️参考联系方式
联系人:黄经理
电话:0519-85859058,13915836899
手机:13915836899
传真:0519-85852385,QQ:3003793626
邮箱:liren_medicine@163.com
通信地址: 江苏省常州市天宁区东仓桥弄1号
邮编: 213000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省常州市天宁区东仓桥弄1号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:S25 | OECDPFAS | List of PFAS from the OECD | DOI:10.5281/zenodo.2648775
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知